NCT05766007View on ClinicalTrials.gov

Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum

RecruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
SchizophreniaPsychosisManiaPregnancyDrug Exposure in UteroDrug Exposure Via Breast MilkAntipsychotic AgentsBreastfeeding
Trial Locations (6)

Unknown

RECRUITING

Federal Medical Centre, Makurdi

RECRUITING

Federal Neuropsychiatric Hospital, Kaduna

RECRUITING

Federal Neuropsychiatric Hospital, Yaba

RECRUITING

Neuropsychiatric Hospital, Abeokuta

RECRUITING

Neuropsychiatric Specialist Hospital, Akure

NOT_YET_RECRUITING

Obafemi Awolowo University Teaching Hospital, Ile-Ife

All Listed Sponsors
collaborator

Federal Neuropsychiatric Hospital, Yaba

UNKNOWN

collaborator

Federal Neuropsychiatric Hospital, Kaduna

UNKNOWN

collaborator

Neuropsychiatric Hospital, Abeokuta

UNKNOWN

collaborator

Neuropsychiatric Specialist Hospital, Akure

UNKNOWN

collaborator

Obafemi Awolowo University Teaching Hospital

OTHER

collaborator

Federal Medical Centre, Makurdi

UNKNOWN

lead

University of Liverpool

OTHER